Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B BERGER

Showing results (721-730 of 937) with videos related to

Pageof 94
Sort By:
Annals of Internal Medicine|July 16, 2003
Management of patients undergoing percutaneous coronary revascularizationGlenn N Levine, Morton J Kern, Peter B Berger, et al.
Complementary Therapies in Medicine|January 24, 2019
Reliability and first validity of the inner correspondence questionnaire for painting therapy (ICPTh) in a sample of breast cancer patientsM Kröz, A Mehl, A Didwiszus, et al.
Circulation. Cardiovascular Interventions|October 20, 2011
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summaryDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Circulation. Cardiovascular Quality and Outcomes|January 15, 2015
Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillationJonathan L Thigpen, Chrisly Dillon, Kristen B Forster, et al.
Catheterization and Cardiovascular Diagnosis|February 1, 1997
Interventional cardiology and intracoronary stents--a changing practice: approved vs. nonapproved indicationsD R Holmes, M R Bell, D R Holmes, et al.
The Canadian Journal of Cardiology|May 15, 2016
Disparities in the Use of Drug-Eluting Coronary Stents by Race, Ethnicity, Payer, and HospitalEdward L Hannan, Michael J Racz, Gary Walford, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrelJuzar O Lokhandwala, Patricia J M Best, Joseph H Butterfield, et al.
American Heart Journal|April 21, 2009
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trialMatthew J Price, Peter B Berger, Dominick J Angiolillo, et al.
Thrombosis and Haemostasis|July 26, 2011
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspectiveDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Journal of the American College of Cardiology|January 1, 1996
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR)P B Berger, D R Holmes, E M Ohman, et al.
Pageof 94

Showing results (721-730 of 937) with videos related to

Sort By:
Pageof 94
Annals of Internal Medicine|July 16, 2003
Management of patients undergoing percutaneous coronary revascularizationGlenn N Levine, Morton J Kern, Peter B Berger, et al.
Complementary Therapies in Medicine|January 24, 2019
Reliability and first validity of the inner correspondence questionnaire for painting therapy (ICPTh) in a sample of breast cancer patientsM Kröz, A Mehl, A Didwiszus, et al.
Circulation. Cardiovascular Interventions|October 20, 2011
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summaryDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Circulation. Cardiovascular Quality and Outcomes|January 15, 2015
Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillationJonathan L Thigpen, Chrisly Dillon, Kristen B Forster, et al.
Catheterization and Cardiovascular Diagnosis|February 1, 1997
Interventional cardiology and intracoronary stents--a changing practice: approved vs. nonapproved indicationsD R Holmes, M R Bell, D R Holmes, et al.
The Canadian Journal of Cardiology|May 15, 2016
Disparities in the Use of Drug-Eluting Coronary Stents by Race, Ethnicity, Payer, and HospitalEdward L Hannan, Michael J Racz, Gary Walford, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrelJuzar O Lokhandwala, Patricia J M Best, Joseph H Butterfield, et al.
American Heart Journal|April 21, 2009
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trialMatthew J Price, Peter B Berger, Dominick J Angiolillo, et al.
Thrombosis and Haemostasis|July 26, 2011
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspectiveDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Journal of the American College of Cardiology|January 1, 1996
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR)P B Berger, D R Holmes, E M Ohman, et al.
Pageof 94